Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)
This grant supports continued research and data collection on long-term health outcomes in childhood cancer survivors, expanding the cohort and serving as a resource for studies to improve cancer treatments.
Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (Full application deadline, projected)
Funding Amounts: Single cooperative agreement award; funding amount not specified in forecast.
Summary: Supports continuation of the Childhood Cancer Survivor Study to investigate long-term outcomes in pediatric and adolescent cancer survivors.
Key Information: Non-competitive, single source award intended for the current CCSS recipient.
Description
This forecasted opportunity from the National Cancer Institute (NCI), part of the NIH, will support the ongoing Childhood Cancer Survivor Study (CCSS). The CCSS is a multi-institutional, collaborative research resource with extensive health-related data from over 38,000 five-year survivors of pediatric and adolescent cancer, alongside a sibling control cohort. The program's goal is to collect additional longitudinal data, expand to include survivors treated with modern therapies, and serve as a resource and biorepository for researchers. Research objectives include cancer risk assessments and studies on long-term outcomes to improve treatments for childhood cancer survivors. This is a non-competitive, single-source cooperative agreement intended for the current recipient of the CCSS.
